NCT03099148 - A Study of LY3337641 in Healthy Participants | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

April 4, 2017

Primary Completion Date

May 31, 2017

Study Completion Date

May 31, 2017

Conditions

Healthy

Interventions

DRUG

Reference Formulation (R)

Administered PO

DRUG

LY3337641 (T1)

20 mg PO

DRUG

LY3337641 (T2)

20 mg PO

Trial Locations (2)

117597

For additional information regarding investigative sites for this trial, contact 1-888-545-5972 Mon - Fri, 9 AM to 4 PM or 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri, 9 AM to 5 PM Eastern Time or speak with your personal physician., Singapore

Unknown

For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri, 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST) or speak with your personal physician., Singapore

All Listed Sponsors

lead

Eli Lilly and Company

INDUSTRY